Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Rheumatology
•
Crystal Arthritis
•
CPPD
•
Pseudogout
Can pseudogout ever lead to joint erosion or should an erosion always make you consider an alternative process?
Related Questions
Do you avoid hyaluronic acid injections in patients with chondrocalcinosis on imaging?
Can Milwaukee shoulder present with a large subacromial bursitis, or does it predominantly cause joint effusion/destruction?
What sampling techniques do you use to improve the diagnostic yield of biopsies in a patient with suspected vasculitis and extensive scattered ulceration throughout the GI tract?
Do you prefer using losartan in your patients with hypertension and gout due to its uricosuric effects?
What is your threshold to repeat a kidney biopsy in a patient with a history of lupus nephritis who is on maintenance therapy and develops subtle changes in urinary protein excretion or microscopic hematuria?
How do you manage hepatotoxicity thought to be related to Romosozumab use?
How do you approach patients who identify so strongly with being sick or with a particular diagnostic label that it makes up a significant portion of their identity?
How would you approach a patient with anti-scl70 ab positive sine scleroderma complicated by ILD who also has seropositive RA with active arthritis?
Can anti-cardiolipin or anti-beta-2 glycoprotein antibodies cause prolonged PTT in the absence of a lupus anticoagulant?
How do you approach management of ILD in the presence of weakly positive RF and ANA but no other objective systemic findings of connective tissue disease?
